Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France
We aimed to investigate the immunoglobulin G response and neutralizing activity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among primary health care workers (PHCW) in France and assess the association between the neutralizing activity and several factors, including the coro...
Main Authors: | Dorine Decarreaux, Marie Pouquet, Cecile Souty, Ana-Maria Vilcu, Pol Prévot-Monsacre, Toscane Fourié, Paola Mariela Saba Villarroel, Stephane Priet, Hélène Blanché, Jean-Marc Sebaoun, Jean-François Deleuze, Clément Turbelin, Andréas Werner, Fabienne Kochert, Brigitte Grosgogeat, Pascaline Rabiega, Julien Laupie, Nathalie Abraham, Caroline Guerrisi, Harold Noël, Sylvie Van der Werf, Fabrice Carrat, Thomas Hanslik, Remi Charrel, Xavier De Lamballerie, Thierry Blanchon, Alessandra Falchi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/5/957 |
Similar Items
-
ELISA IgG versus CMIA IgG for detection of SARS-CoV-2-specific antibodies in COVID-19 patients
by: Pathum Sookaromdee, et al.
Published: (2022-01-01) -
Characterizing A “N-CoV-2-IgG PS” diagnostic kit to quantify SARS-CoV-2 nucleocapsid protein-specific human IgG antibodies
by: Elena V. Zueva, et al.
Published: (2022-11-01) -
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
by: Lisandru Capai, et al.
Published: (2020-11-01) -
Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis
by: Kathleen Mahan, et al.
Published: (2024-03-01) -
Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
by: Baolin Liao, et al.
Published: (2021-08-01)